80 Participants Needed

QL Block for Postoperative Pain in Hip Surgery

HB
JS
PC
Overseen ByPamela Chia, MD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: University of California, Los Angeles
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop taking my current medications for the trial?

The trial information does not specify if you need to stop taking your current medications. However, if you are using opioids regularly, you may not be eligible to participate.

What data supports the effectiveness of the treatment Quadratus Lumborum Block for postoperative pain in hip surgery?

Research shows that the Quadratus Lumborum Block is effective in reducing pain after hip surgery, as it provides better pain relief compared to no block or other pain management techniques. Studies have found it to be beneficial in managing pain after hip arthroplasty, with patients experiencing less need for additional pain medication.12345

Is the QL Block safe for humans?

The QL Block, used for pain relief after surgeries like hip replacements, has been studied in various forms and is generally considered safe. It is a regional anesthetic technique that has been used effectively without major safety concerns reported in the studies.12367

How does the QL block treatment differ from other treatments for postoperative pain in hip surgery?

The QL block is a novel regional anesthetic technique that provides pain relief by targeting specific nerve branches in the lower back, which can reduce the need for opioids and minimize muscle weakness compared to other pain management methods.12345

What is the purpose of this trial?

The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).

Research Team

PC

Pamela Chia, MD

Principal Investigator

University of California, Los Angeles

Eligibility Criteria

This trial is for adults having elective primary total hip arthroplasty. It's not suitable for those under 18, with allergies to local anesthetics, peripheral neuropathy, long-term opioid use, or conditions that contraindicate spinal and regional anesthesia like coagulopathy or site infections.

Inclusion Criteria

I am an adult scheduled for my first total hip replacement surgery.

Exclusion Criteria

I cannot have spinal or regional anesthesia due to a bleeding disorder or an infection.
I experience numbness, tingling, or pain in my hands or feet.
I am under 18 years old.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a quadratus lumborum nerve block with either ropivacaine or saline during primary total hip arthroplasty

Immediate perioperative period
1 visit (in-person, surgical procedure)

Postoperative Monitoring

Pain scores and opioid usage are assessed over the first 48 hours after surgery

48 hours

Follow-up

Participants are monitored for patient satisfaction, time to ambulation, and other recovery metrics until discharge

Up to 1 week post surgery

Treatment Details

Interventions

  • Quadratus Lumborum Block
Trial Overview The study tests the effectiveness of Quadratus Lumborum (QL) blocks in managing pain after hip replacement surgery. Participants will be randomly assigned to receive either the QL block (active comparator) or a placebo.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Intervention GroupActive Control1 Intervention
Quadratus lumborum nerve block with 0.25% ropivacaine
Group II: Control GroupPlacebo Group1 Intervention
Quadratus lumborum nerve block with saline

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+

Findings from Research

The quadratus lumborum (QL) block significantly reduces opioid consumption by approximately 15.78 mg in the first 24 hours after hip surgery compared to placebo or no block, indicating its efficacy in postoperative pain management.
Patients receiving the QL block reported a reduction in pain during movement, with a pain grade decrease of 2.95 compared to those who did not receive the block, suggesting improved analgesia without affecting static pain scores.
Postoperative analgesic effectiveness of quadratus lumborum block: systematic review and meta-analysis for adult patients undergoing hip surgery.Xiong, H., Chen, X., Zhu, W., et al.[2022]
In a study of 80 patients undergoing total hip arthroplasty, the quadratus lumborum (QL) block significantly reduced pain scores and opioid consumption for up to 48 hours post-surgery compared to a control group without the block.
Patients receiving the QL block reported higher satisfaction scores, indicating that this technique not only provides effective pain relief but also enhances the overall patient experience after surgery.
Anterior quadratus lumborum block analgesia for total hip arthroplasty: a randomized, controlled study.Kukreja, P., MacBeth, L., Sturdivant, A., et al.[2021]
The ultrasound-guided quadratus lumborum (QL) block significantly reduced pain during mobilization and opioid consumption at 48 hours post-hip arthroplasty, showing clinical significance compared to the non-QL block group in a meta-analysis of 11 trials with 830 patients.
The QL block also improved patient satisfaction and reduced the incidence of postoperative nausea and vomiting, although its impact on pain at rest and opioid use at earlier time points did not reach minimal clinically important difference (MCID).
Efficacy of Ultrasound-Guided Quadratus Lumborum Block for Postoperative Analgesia After Hip Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.Hu, Z., Zhang, Z., Tian, X.[2023]

References

Postoperative analgesic effectiveness of quadratus lumborum block: systematic review and meta-analysis for adult patients undergoing hip surgery. [2022]
Anterior quadratus lumborum block analgesia for total hip arthroplasty: a randomized, controlled study. [2021]
Efficacy of Ultrasound-Guided Quadratus Lumborum Block for Postoperative Analgesia After Hip Arthroplasty: A Meta-Analysis of Randomized Controlled Trials. [2023]
Ultrasound-Guided Oblique Sagittal Anterior Quadratus Lumborum Block in Total Hip Arthroplasty: A Randomized Controlled Trial. [2022]
Ultrasound-guided anterior and posterior quadratus lumborum block for analgesia after laparoscopic hysterectomy. [2021]
Ultrasound-guided quadratus lumborum block as a postoperative analgesic technique for laparotomy. [2022]
Transmuscular Quadratus Lumborum Block versus Infrainguinal Fascia Iliaca Nerve Block for Patients Undergoing Elective Hip Replacement: A Double-blinded, Pilot, Randomized Controlled Trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity